DOSIMERTINIB

Details

Stereochemistry	ACHIRAL
Molecular Formula	C28H33N7O2
Molecular Weight	504.6381
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[2H]C([2H])=CC(=O)NC1=CC(NC2=NC=CC(=N2)C3=CN(C4=CC=CC=C34)C([2H])([2H])[2H])=C(OC)C=C1N(C)CCN(C)C

InChI

InChIKey=DUYJMQONPNNFPI-ZFTIYMCPSA-N

InChI=1S/C28H33N7O2/c1-7-27(36)30-22-16-23(26(37-6)17-25(22)34(4)15-14-33(2)3)32-28-29-13-12-21(31-28)20-18-35(5)24-11-9-8-10-19(20)24/h7-13,16-18H,1,14-15H2,2-6H3,(H,30,36)(H,29,31,32)/i1D2,5D3

HIDE SMILES / InChI

Molecular Formula	C28H33N7O2
Molecular Weight	504.6381
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Sat Dec 16 19:06:58 GMT 2023` Edited by `admin` on `Sat Dec 16 19:06:58 GMT 2023`
Record UNII	K294YWL36N
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

DOSIMERTINIB

Common Name

English

2-Propenamide-3,3-d2, N-[2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-[1-(methyl-d3)-1H-indol-3-yl]-2-pyrimidinyl]amino]phenyl]-

Systematic Name

English

Code System Code Type Description

PUBCHEM

162623670

Created by admin on Sat Dec 16 19:06:59 GMT 2023 , Edited by admin on Sat Dec 16 19:06:59 GMT 2023

PRIMARY

FDA UNII

K294YWL36N

Created by admin on Sat Dec 16 19:06:59 GMT 2023 , Edited by admin on Sat Dec 16 19:06:59 GMT 2023

PRIMARY

CAS

2403760-70-1

Created by admin on Sat Dec 16 19:06:59 GMT 2023 , Edited by admin on Sat Dec 16 19:06:59 GMT 2023

PRIMARY

Related Record Type Details


					Z8GA0YQ49Y

EPIDERMAL GROWTH FACTOR RECEPTOR T790M MUTANT

TARGET -> INHIBITOR

Interaction Type:

IRREVERSIBLE INHIBITOR

Amount:


					PUO0521HZV

CYTOCHROME P450 3A4

METABOLIC ENZYME -> SUBSTRATE

Interaction Type:

MAJOR

Amount:


					L0423Z5LDW

CYTOCHROME P450 2C8

METABOLIC ENZYME -> SUBSTRATE

Interaction Type:

MINOR

Amount:


					7CPN3DPX52

DOSIMERTINIB MESYLATE

SALT/SOLVATE -> PARENT

Amount:


					RO03J093CP

EPIDERMAL GROWTH FACTOR RECEPTOR

TARGET -> INHIBITOR

Qualification:

IC50

Amount:


					YA9G51KO3E

EPIDERMAL GROWTH FACTOR RECEPTOR T790M, L858R MUTANT

TARGET -> INHIBITOR

Comments:

Covalently and irreversibly binds to cysteine 797 in the ATP binding site of EGFR, exhibiting 200 times greater potency towards EGFRm/T790M than EGFRWT

Interaction Type:

IRREVERSIBLE INHIBITOR

Qualification:

IC50

Amount:

Related Record Type Details


					K294YWL36N

DOSIMERTINIB

ACTIVE MOIETY

Comments:

Deuterium-containing dosimertinib that exhibited robust antitumor activity and lower toxicity against NSCLC compared to osimertinib.

Amount: